ArticleJHLT open2025
Lung transplant outcomes by surgeon practice and volume.
Article in JHLT open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Lung transplants (LT) are performed by surgeons whose practice may include only lung transplants (LT) or lung and heart transplants (L&HT). We examined whether LT outcomes differed by surgeon practice and volume. Methods: We identified all LT in adult U.S. recipients 05/2007-06/2022 using OPTN. We classified surgeons by practice (LT vs. L&HT) and LT volume (2-20, 21-40, 41-60, or >60) and compared post-transplant morbidity and mortality using multivariable regression adjusted for donor, recipient, and transplant characteristics. Results: Of 635 surgeons, 331 (51.1%) were LT and 304 (47.9%) were L&HT surgeons. They performed 30,223 transplants, including 9807 (32.5%) by LT and 20,416 (67.5%) by L&HT surgeons. Recipients of transplants by L&HT vs. LT surgeons were less likely to receive post-transplant ECMO (7.9% vs. 8.5%; aOR 0.86, 0.76-0.97, p=0.02) but had similar odds of prolonged ventilation (31.3% vs. 31.5%; aOR 1.01, 95% CI 0.94-1.08, p=0.87), reintubation (18.6% vs. 18.3%; aOR 1.04, 0.98-1.11, p=0.20), airway dehiscence (1.5% vs. 1.6%; aOR 1.01., 0.82-1.23, p=0.94), and 1-year rejection (24.1% vs. 23.0%; aOR 1.04, 0.98-1.12, p=0.20), and they had 4% higher risk of 10-year mortality (70.0% vs. 67.6%; aHR 1.04, 95% CI 1.00-1.08, p=0.046). Additionally, performing >60 lung transplants over the study period was associated with 7% lower 5-year mortality compared to performing only 2-20 transplants (aHR 0.93, 95% CI 0.88-0.98, p=0.004). Conclusions: Surgeons' practice patterns and lung transplant volume were significantly associated with post-transplant mortality, indicating the importance of experience in achieving optimal outcomes for a technically difficult procedure such as a lung transplant.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.